Search research articles
Contact Us
Filters
Showing results (1-10 of 142) with videos related to
Page
of 15
Sort By:
Immunity
|
December 21, 2017
RAS and PD-L1: A Masters' Liaison in Cancer Immune Evasion
Nicole Glodde, Michael Hölzel
Immunity
|
September 16, 2020
Not Sweet: Glucocorticoids from Intratumoral Myeloid Cells Disable T Cells
Maike Effern, Michael Hölzel
Trends in Immunology
|
May 7, 2016
Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis
Michael Hölzel, Thomas Tüting
Nature Reviews. Cancer
|
March 29, 2013
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
Michael Hölzel, Anton Bovier, Thomas Tüting
European Journal of Cancer (Oxford, England : 1990)
|
October 25, 2025
Can NaCl predict or even enhance responses to immunotherapy in cancer?
Jonas Saal, Michael Hölzel, Niklas Klümper
Cancer Research
|
December 16, 2024
C-Reactive Protein Facilitates Premetastatic Niche Formation in the Lungs
Jonas Saal, Niklas Klümper, Michael Hölzel
European Urology
|
May 14, 2024
The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer
Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al.
Advances in Cancer Research
|
April 11, 2007
c-MYC impairs immunogenicity of human B cells
Martin Schlee, Marino Schuhmacher, Michael Hölzel, et al.
Oncotarget
|
February 5, 2011
The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword
Michael Hölzel, Kaspar Burger, Bastian Mühl, et al.
Journal of Clinical Medicine
|
November 13, 2021
Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?
Barbara Link, Adriana Torres Crigna, Michael Hölzel, et al.
Page
of 15
Search research articles
Search
Showing results (1-10 of 142) with videos related to
Sort By:
Page
of 15
Immunity
|
December 21, 2017
RAS and PD-L1: A Masters' Liaison in Cancer Immune Evasion
Nicole Glodde, Michael Hölzel
Immunity
|
September 16, 2020
Not Sweet: Glucocorticoids from Intratumoral Myeloid Cells Disable T Cells
Maike Effern, Michael Hölzel
Trends in Immunology
|
May 7, 2016
Inflammation-Induced Plasticity in Melanoma Therapy and Metastasis
Michael Hölzel, Thomas Tüting
Nature Reviews. Cancer
|
March 29, 2013
Plasticity of tumour and immune cells: a source of heterogeneity and a cause for therapy resistance?
Michael Hölzel, Anton Bovier, Thomas Tüting
European Journal of Cancer (Oxford, England : 1990)
|
October 25, 2025
Can NaCl predict or even enhance responses to immunotherapy in cancer?
Jonas Saal, Michael Hölzel, Niklas Klümper
Cancer Research
|
December 16, 2024
C-Reactive Protein Facilitates Premetastatic Niche Formation in the Lungs
Jonas Saal, Niklas Klümper, Michael Hölzel
European Urology
|
May 14, 2024
The Role of Microsatellite Instability/DNA Mismatch Repair Deficiency and Tumor Mutational Burden as Biomarkers in Predicting Response to Immunotherapy in Castration-resistant Prostate Cancer
Niklas Klümper, Viktor Grünwald, Arndt Hartmann, et al.
Advances in Cancer Research
|
April 11, 2007
c-MYC impairs immunogenicity of human B cells
Martin Schlee, Marino Schuhmacher, Michael Hölzel, et al.
Oncotarget
|
February 5, 2011
The tumor suppressor p53 connects ribosome biogenesis to cell cycle control: a double-edged sword
Michael Hölzel, Kaspar Burger, Bastian Mühl, et al.
Journal of Clinical Medicine
|
November 13, 2021
Abscopal Effects in Metastatic Cancer: Is a Predictive Approach Possible to Improve Individual Outcomes?
Barbara Link, Adriana Torres Crigna, Michael Hölzel, et al.
Page
of 15